Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.
United Therapeutics (UTHR): In an exclusive interview, Cramer sat down with Dr. Martine Rothblatt, chairman and co-CEO of United Therapeutics, the biotech with four drugs on the market treating pulmonary arterial hypertension.
Rothblatt explained that she first started United Therapeutics after her youngest daughter was diagnosed with a rare for of hypertension and given just three years to live. She said that thanks to their research and development, her daughter continues to survive by taking a pill just a few times a day, as compared to a 24-hour-a-day infusion pump, which was the course of treatment before United Therapeutics.
While pulmonary arterial hypertension is considered a rare disease, there are still over 30,000 patients in the U.S. alone that suffer from it. Rothblatt said that reaching those patients is critical and they've been accomplishing that through patient associations.
Even with the stock up 37.5% so far in 2015, Cramer thinks it's inexpensive given this company's fascinating story.